Mineralys Therapeutics Inc. Common Stock Analysis
| Analyst Ratings |
|
Average Target Price
|
35.75
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
5
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-12-31
|
-0.83
|
0.00
|
0.83
|
100.00%
|
|
2023-09-30
|
-0.76
|
-0.57
|
0.19
|
25.00%
|
|
2023-06-30
|
-0.72
|
-0.31
|
0.41
|
56.94%
|
|
2023-03-31
|
-0.89
|
-0.51
|
0.38
|
42.70%
|
|
2022-12-31
|
-1.72
|
-1.74
|
-0.02
|
-1.16%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2023-12-31
|
-1.39
|
|
2022-12-31
|
-1.74
|